Education
About Us
Working with TipRanks
Follow Us
Cogent Biosciences (COGT)
NASDAQ:COGT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -4.62M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -333.36M | $ -275.94M | $ -208.13M | $ -147.84M | $ -75.55M |
| EBITDA | $ -328.74M | $ -271.59M | $ -204.54M | $ -141.96M | $ -73.56M |
| Net Income | $ -328.94M | $ -255.86M | $ -192.41M | $ -140.24M | $ -72.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 900.76M | $ 287.08M | $ 265.71M | $ 259.28M | $ 219.68M |
| Total Assets | $ 937.61M | $ 327.90M | $ 313.44M | $ 300.81M | $ 232.09M |
| Total Debt | $ 253.15M | $ 17.47M | $ 18.85M | $ 19.65M | $ 3.15M |
| Net Debt | $ -58.86M | $ -80.70M | $ -34.38M | $ -120.24M | $ -216.53M |
| Total Liabilities | $ 301.24M | $ 71.61M | $ 55.63M | $ 45.08M | $ 17.91M |
| Stockholders' Equity | $ 636.37M | $ 256.29M | $ 257.80M | $ 255.74M | $ 214.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -266.00M | $ -208.36M | $ -156.42M | $ -125.50M | $ -60.48M |
| Operating Cash Flow | $ -264.44M | $ -207.79M | $ -153.62M | $ -118.64M | $ -58.76M |
| Investing Cash Flow | $ -399.53M | $ 38.28M | $ -97.82M | $ -124.72M | $ -1.72M |
| Financing Cash Flow | $ 878.23M | $ 214.45M | $ 163.54M | $ 163.56M | $ 37.98M |